Thulium Laser Enucleation With Bladder Neck Incision for Small-Volume Benign Prostatic Hyperplasia
- Sponsor
- Chinese PLA General Hospital
- Study ID
- NCT07569874
- Status
- Recruiting
Conditions
- Benign Prostatic Hyperplasia
- Bladder Outlet Obstruction
- Lower Urinary Tract Symptoms (LUTS)
Eligibility Criteria
- Sex
- MALE
- Age
- 40 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Thulium Laser Enucleation of the Prostate Combined With Bladder Neck Incision — PROCEDUREParticipants will undergo transurethral thulium laser enucleation of the prostate combined with bladder neck incision. Hyperplastic prostatic tissue will be enucleated along the surgical capsule plane using a thulium fibre laser system. After enucleation and haemostasis, the bladder neck will be assessed intraoperatively, and bladder neck incision will be performed according to protocol-defined anatomical and obstructive findings when considered safe by the operating surgeon.
- Thulium Laser Enucleation of the Prostate — PROCEDUREParticipants will undergo transurethral thulium laser enucleation of the prostate alone. Hyperplastic prostatic tissue will be enucleated along the surgical capsule plane using a thulium fibre laser system, followed by haemostasis of the surgical wound. No bladder neck incision will be performed as part of the assigned intervention.
- Transurethral Resection of the Prostate — PROCEDUREParticipants will undergo transurethral resection of the prostate using a conventional resectoscope. Obstructive hyperplastic prostatic tissue will be resected transurethrally according to standard TURP principles to relieve obstruction while avoiding excessive resection and injury to adjacent structures.
Study Details
This study will evaluate the safety and effectiveness of thulium laser enucleation of the prostate combined with bladder neck incision in men with small-volume benign prostatic hyperplasia (BPH). Small-volume BPH may still cause significant bladder outlet obstruction and bothersome lower urinary tract symptoms, and the optimal surgical treatment for these patients remains uncertain. In this multicenter, randomized, single-blind, controlled trial, 426 eligible men aged 40 to 80 years will be assigned in a 1:1:1 ratio to one of three groups: thulium laser enucleation of the prostate combined with bladder neck incision, thulium laser enucleation alone, or transurethral resection of the prostate. The main goal is to compare the incidence of bladder neck contracture at 6 months after surgery. Other outcomes include symptom improvement, urinary flow, pain score, sexual function, and safety outcomes during follow-up.
Key Dates
- Start date
- May 31, 2026
- Status verified
- Apr 2026
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 426 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: ThuLEP Combined With Bladder Neck IncisionParticipants assigned to this arm will undergo thulium laser enucleation of the prostate combined with bladder neck incision. Hyperplastic prostatic tissue will be enucleated along the surgical capsule plane using a thulium fibre laser system. After enucleation and haemostasis, the bladder neck will be assessed intraoperatively, and bladder neck incision will be performed according to protocol-defined anatomical and obstructive findings when considered safe by the operating surgeon.
- Active Comparator: ThuLEP AloneParticipants assigned to this arm will undergo thulium laser enucleation of the prostate alone. The procedure will be performed transurethrally, and hyperplastic prostatic tissue will be enucleated along the surgical capsule plane using a thulium fibre laser system, followed by haemostasis of the surgical wound.
- Active Comparator: Transurethral Resection of the ProstateParticipants assigned to this arm will undergo transurethral resection of the prostate using a conventional resectoscope. Obstructive hyperplastic prostatic tissue will be resected transurethrally according to standard TURP principles to relieve obstruction while avoiding excessive resection and injury to adjacent structures.
Primary Outcome Measure
Incidence of Bladder Neck Contracture [ Time Frame: 6 months after surgery (180 ± 7 days) ]
Central Contacts
- Qing Yuan, MD, PhD+8618910980422
Related Studies
- Fetal Cystoscopy for Severe Lower Urinary Tract ObstructionRecruiting · Rodrigo Ruano · Miami, Florida
- 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI TherapyRecruiting · Beth Israel Deaconess Medical Center · Boston, Massachusetts
- Concomitant Renal and Urinary Bladder Allograft TransplantationEARLY_PHASE1 · Recruiting · Mayo Clinic · Rochester, Minnesota
- Customized TULSA-PRO Ablation RegistryRecruiting · Profound Medical Inc. · West Hills, California